Ilaprzole patent to be extended by 2027

Published: 2009-05-21 06:58:00
Updated: 2009-05-21 06:58:00
Ilyang Pharm says the patent right of its ulcer drug ilaprozole will be protected by 2027 in the United States after an 8-month negotiation with TAP Pharmaceutical.

So far, TAP completed phase II trials for a novel ilaprazole in the U.S. Thus Ilyang has sought protection of patent rights for s...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.